APA (7th ed.) Citation

Zhou, Q., & Wang, R. Cooperative targeting of NF-κB enhances ferroptosis-driven HCC therapy with Alisertib and Donafenib. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhou, Qiong, and Rui Wang. Cooperative Targeting of NF-κB Enhances Ferroptosis-driven HCC Therapy with Alisertib and Donafenib. Frontiers Media S.A.

MLA (9th ed.) Citation

Zhou, Qiong, and Rui Wang. Cooperative Targeting of NF-κB Enhances Ferroptosis-driven HCC Therapy with Alisertib and Donafenib. Frontiers Media S.A.